OncLive - Bringing the Oncology Community Together

An interim analysis revealed that the immunotherapy rocapuldencel-T is unlikely to meet any of the primary endpoints of the phase III ADAPT trial in patients with metastatic renal cell carcinoma. Read More >>

Diet Linked With Tumor Aggressiveness in Endometrial Cancer

Fonseca Discusses Integrating Biology and Treatment in Multiple Myeloma

FDA Approves Frontline Osimertinib for NSCLC

FDA Grants Nivolumab Priority Review for SCLC

Streamlined, Oncologist-Led BRCA Testing Viable in Ovarian Cancer

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

Dr. Ginsburg Addresses Global Disparities in Cervical Cancer

Dr. Topalian on the Treatment of Nasopharyngeal Carcinoma

Dr. Kaplan on Treating Solid Tumors in Pediatric Patients

Dr. Ferris on the Updated Data from CheckMate-141 in Head and Neck Cancer

Dr. Jhaveri on Results of Taselisib in PIK3CA-Mutated Metastatic Solid Tumors

Dr. Paik on Resistance Mutations in NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Supportive Care in Metastatic CRC

Treatment Challenges in Nonmetastatic CRPC

Other Promising Targets in TNBC

Take-Home Messages on Breast Oncology Advances

Defining Recurrence in Patients With Metastatic RCC

Maintenance and Second-Line Decisions in CRC

Detecting Newly Diagnosed Metastatic Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Rationale Behind Antiangiogenic Therapy in NSCLC

Future Outlook in Pancreatic Cancer

PD-L1 Testing in Metastatic NSCLC

Radiotherapy Strategies in Locally Advanced NSCLC

Impact of Prognostic Factors on Clinical Decisions in CLL

Promising New Therapies in Pancreatic Cancer

Pancreatic Cancer: Looking Beyond Second-Line Therapy

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

FDA Approves Blinatumomab for MRD+ ALL

The FDA has granted an accelerated approval to blinatumomab for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in Ovarian Cancer, Priority Reviews in NSCLC, CLL, and Follicular Lymphoma, and More